Work

P2.03a-065 Lack of Drug-Drug Interaction (DDI) between Necitumumab and Gemcitabine or Cisplatin: A Phase 2, Open-Label, Nonrandomized Study

Year: 2017

Type: article

Study design: Clinical Trial

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2016.11.1275

Authors: Archana Chaudhary, Grace Chao, Fadi Braiteh, Michael Gordon, James Lee, Patricia Lorusso, Coleman Obasaju, Johan Wallin

Institutions: Eli Lilly (United States), Comprehensive Cancer Centers of Nevada, Pinnacle Oncology Hematology, UPMC Hillman Cancer Center, Yale Cancer Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2770681897

FWCI:

Cites:

Cited by:

Related to: 10